Actively Recruiting

Age: 18Years - 85Years
All Genders
ID07284446

Prevalence of Depressive Symptoms and Cognitive Impairment and Their Association With Worse Outcomes in Hospitalized Patients With Chronic Heart Failure

Led by Lithuanian University of Health Sciences · Updated on 2025-12-16

300

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are studying hospitalized patients aged 18 to 85 years with chronic heart failure (CHF) to understand how common depressive symptoms and cognitive impairment are and how they relate to worse health outcomes. This observational study focuses on patients admitted due to worsening CHF and aims to determine if these mental health and cognitive issues lead to increased mortality or rehospitalizations. The study is conducted at a single center where most CHF patients in the region receive inpatient care. Participants who stabilize during their hospital stay will complete validated questionnaires assessing depression and cognitive function about 48 hours after stabilization and again at discharge. The questionnaires include the Patient Health Questionnaire-9 (PHQ-9), Hospital Anxiety and Depression Scale (HADS), and Montreal Cognitive Assessment (MoCA). Clinical data, treatments, and procedures during hospitalization will also be collected to explore how these factors relate to outcomes. During their participation, patients will undergo physical exams and provide demographic and clinical information. Researchers will track key outcomes such as death from any cause during and after hospitalization and CHF-related rehospitalizations over 12 months post-discharge. Data will be analyzed to identify links between depressive symptoms, cognitive impairment, and these health outcomes. The study aims to inform better screening and management of mental health and cognitive issues in CHF care.

CONDITIONS

Brief Title

Depressive Symptoms, Cognitive Impairment, and Outcomes in Hospitalized Chronic Heart Failure Patients

Who Can Participate

Age: 18Years - 85Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Patient hospitalized primarily for CHF exacerbation
  • Clinically stable and able to provide informed consent
  • No severe cognitive impairment that prevents valid questionnaire completion
Not Eligible

You will not qualify if you...

  • Hospitalization for acute heart failure
  • Total hospital stay less than 96 hours
  • No transthoracic echocardiography within the last 12 months and none planned
  • Severe visual impairment preventing completion of visual parts of assessments
  • Refusal to participate

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person) during hospitalization after clinical stabilization

Diagnostic Evaluation

Duration - Approximately duration of the hospital stay, up to 30 days

Participants undergo assessments of depressive symptoms and cognitive function using standardized questionnaires during hospitalization.

2 visits (in-person) - one approximately 48 hours after stabilization and one on the last day of hospital stay

Long-term Monitoring

Duration - 12 months post discharge

Participants are followed for clinical outcomes including mortality and CHF-related rehospitalizations after hospital discharge.

Follow-up assessments occur up to 12 months after discharge; specific visit frequency not fixed

Trial Site Locations

Total: 1 location

1

Kaunas Hospital of the Lithuanian University of Health Sciences

Kaunas, Lithuania, 47144

Actively Recruiting

Loading map...

Research Team

A

Andrius Ališauskas, MD, PhD

K

Kornelija Dzikevičiūtė, MD

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Similar Trials

A Pilot Study on the Efficacy of a Synbiotic Formula (MQU10)...

Depressive Symptoms Mild to Moderate in Severity

Actively Recruiting

2 locations

Adolescent Depression Treatment Pathways in Primary Care A L...

Depressive Symptoms Mild to Moderate in Severity

Actively Recruiting

4 locations

Smart Monitoring and Analysis System Based on Artificial Int...

Chronic Heart Failure

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Prognostic Value of Transthoracic Impedance Cardiography, Amino-Terminal Pro-B-Type Natriuretic Peptide Levels, The Six-Minute Walk Test, and Chest X-Ray in Elderly Patients with Chronic Heart Failure: A Comparative Study in Lithuania.

Andrius Ališauskas, Kornelija Dzikevičiūtė, Urtė Rimšaitė...

https://pubmed.ncbi.nlm.nih.gov/39327721

Single-Center Study in Lithuania to Evaluate the Role of Transthoracic Impedance Cardiography in the Diagnosis and Outcome Evaluation of 301 Patients with Chronic Heart Failure Exacerbation.

Andrius Ališauskas, Albinas Naudžiūnas, Saulius Sadauskas...

https://pubmed.ncbi.nlm.nih.gov/36564931

Diagnostic and Outcome Prediction Value of Transthoracic Impedance Cardiography in Heart Failure Patients During Heart Failure Flare-Ups.

Saulius Sadauskas, Albinas Naudžiūnas, Alvydas Unikauskas...

https://pubmed.ncbi.nlm.nih.gov/30227444